Apotex Asks High Court To Deny Review Of Panel’s Reversal In Patent Drug Suit
WASHINGTON, D.C. — Apotex Inc. argues in an Oct. 5 opposition brief that the U.S. Supreme Court should not review a drug patent infringement lawsuit over efforts to end a company’s...To view the full article, register now.
Already a subscriber? Click here to view full article